Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Curexo Inc. (060280:KRX), powered by AI.
Curexo Inc. is currently trading at ₩15,810. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Curexo Inc. on Alpha Lenz.
Curexo Inc.'s P/E ratio is 235.4.
“Curexo Inc. trades at a P/E of 235.4 (premium valuation) with modest ROE of 2.9%.”
Ask for details →Curexo Inc. is a company dedicated to the development and commercialization of medical and healthcare robotic systems. As a leader in the medical technology sector, Curexo focuses on enhancing surgical precision and patient outcomes by integrating advanced robotics into healthcare solutions. The company's primary offerings include robotic-assisted surgery systems, which are designed to support orthopedic and spine surgeries with enhanced accuracy and reduced recovery times. Additionally, Curexo invests heavily in research and development to innovate within the fields of orthopedic implants and rehabilitation systems. Operating at the intersection of healthcare and technology, Curexo plays a vital role in modernizing surgical procedures and expanding the capabilities of medical professionals. Its innovations contribute significantly to the advancement of surgical robotics in various markets. Based in South Korea, Curexo Inc. collaborates with hospitals and medical institutions globally, ensuring that its cutting-edge technology is widely accessible, thereby influencing positive shifts in healthcare practices and outcomes.
“Curexo Inc. trades at a P/E of 235.4 (premium valuation) with modest ROE of 2.9%.”
Ask for details →Curexo Inc. (ticker: 060280) is a company listed on KRX in the Common Stock sector (Common Stock). Market cap is $652.3B.
The current price is ₩15,810 with a P/E ratio of 235.37x and P/B of 6.78x.
ROE is 2.92% and operating margin is 3.17%. Annual revenue is $74.5B.